Bile Acids Are Potential Negative Allosteric Modulators of M1 Muscarinic Receptors
Biomolecules · 2025
DOI: 10.3390/biom15091326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Wenbo Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Computer-Aided Drug Design Center, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland Baltimore, Baltimore, MD 21201, …. Hauptthemen laut MEDLINE: Bile Acids and Salts, Receptor, Muscarinic M1. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
The proposed physiological roles of bile acids have expanded beyond the digestion of fats to encompass cell signaling via the activation of a variety of nuclear and plasma membrane receptors in multiple organ systems. The current in silico study was inspired by previous observations from our group and others that bile acids interact functionally with cardiac, pulmonary, and gastrointestinal muscarinic receptors and more recent work demonstrating allosteric binding of cholesterol, the parent molecule for bile acid synthesis, to M1 muscarinic receptors (M1R). Here, we computationally tested the hypothesis that bile acids can allosterically bind to M1R and thereby modulate receptor activation. Utilizing de novo site identification by the ligand competitive saturation (SILCS) method, putative novel allosteric binding sites of bile acid targeting M1R were identified. Molecular dynamics simulations were used to uncover the molecular details of the activation mechanism of M1R due to agonist binding along with allosteric modulation of bile acids on M1R activation. Allosteric binding of bile acids and their glycine and taurine conjugates to M1R negatively impacts the activation process, findings consistent with recent reports that M1R expression and activation inhibit colon cancer cell proliferation. Thus, bile acids may augment colon cancer risk by inhibiting the tumor suppressor actions of M1R. When validated experimentally, these findings are anticipated to shed light on our understanding of how bile acids in the membrane microenvironment can allosterically modulate the function of M1R and possibly other G protein-coupled receptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Computer-Aided Drug Design Center, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland Baltimore, Baltimore, MD 21201, USA.
- Institute for Bioscience and Biotechnology Research (IBBR), Rockville, MD 20850, USA.
- Center for Biomolecular Therapeutics (CBT), School of Medicine, University of Maryland Baltimore, Baltimore, MD 21201, USA.
- Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- VA Maryland Healthcare System, Baltimore, MD 21201, USA.
ORCID-Profile: Wenbo Yu, Alexander D MacKerell, David J Weber, Jean-Pierre Raufman
Förderung
- BLRD VA
- NIGMS NIH HHS
- NIH HHS
- United States Department of Veterans Affairs
- United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development Program
- NIH
- University of Maryland Computer-Aided Drug Design Center
Zitieren
APA
Yu, W., MacKerell, A. D., Weber, D. J., & Raufman, J. P. (2025). Bile Acids Are Potential Negative Allosteric Modulators of M1 Muscarinic Receptors. Biomolecules. https://doi.org/10.3390/biom15091326
Vancouver
Yu W, MacKerell AD, Weber DJ, Raufman JP. Bile Acids Are Potential Negative Allosteric Modulators of M1 Muscarinic Receptors. Biomolecules. 2025. doi:10.3390/biom15091326
BibTeX
@article{Yu2025,
author = {Yu, Wenbo and MacKerell, Alexander D and Weber, David J and Raufman, Jean-Pierre},
title = {Bile Acids Are Potential Negative Allosteric Modulators of M1 Muscarinic Receptors},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15091326}
}
EUVIMED